| MET-PET for Newly Diagnosed Glioblastoma (NCT01867593) | Massachusetts General Hospital | 2014-01-01 |
| Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens (NCT01854099) | University of Florida | 2014-01-01 |
| Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma (NCT02039778) | Beth Israel Medical Center | 2013-12-01 |
| Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma (NCT01957956) | Mayo Clinic | 2013-11-11 |
| An Efficacy Study Of Ortataxel In Recurrent Glioblastoma (NCT01989884) | Mario Negri Institute for Pharmacological Research | 2013-11-01 |
| Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma (NCT01849146) | National Cancer Institute (NCI) | 2013-10-24 |
| NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme (NCT01954576) | University of Florida | 2013-10-10 |
| Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide (NCT01907165) | Washington University School of Medicine | 2013-10-10 |
| Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas (NCT01849952) | Dartmouth-Hitchcock Medical Center | 2013-10-09 |
| ANG1005 in Patients With Recurrent High-Grade Glioma (NCT01967810) | Angiochem Inc | 2013-10-01 |
| Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas (NCT01922076) | National Cancer Institute (NCI) | 2013-09-03 |
| A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma (NCT01860638) | Hoffmann-La Roche | 2013-08-19 |
| MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme (NCT01851733) | Washington University School of Medicine | 2013-08-13 |
| p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors (NCT01975116) | Pediatric Brain Tumor Consortium | 2013-08-01 |
| A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma (NCT01939574) | Shandong Cancer Hospital and Institute | 2013-08-01 |
| A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm (NCT01905228) | Incuron | 2013-07-01 |
| Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM) (NCT01782976) | M.D. Anderson Cancer Center | 2013-06-01 |
| Tivozanib for Recurrent Glioblastoma (NCT01846871) | Massachusetts General Hospital | 2013-06-01 |
| Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM (NCT02085304) | St. Joseph's Hospital and Medical Center, Phoenix | 2013-05-07 |
| Valproic Acid in Childhood Progressive Brain Tumors (NCT01861990) | Medical University of South Carolina | 2013-05-01 |
| Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study (NCT01872221) | Institut Claudius Regaud | 2013-05-01 |
| Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma (NCT01810744) | Centre Georges Francois Leclerc | 2013-05-01 |
| Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma (NCT02841332) | University Hospital, Toulouse | 2013-05-01 |
| A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG) (NCT01602588) | University College, London | 2013-05-01 |
| Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma (NCT01817751) | Virginia Commonwealth University | 2013-04-11 |
| A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme (NCT01752491) | Joseph J. Cullen, MD, FACS | 2013-04-01 |
| Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery (NCT01798771) | Johann Wolfgang Goethe University Hospital | 2013-03-01 |
| Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors (NCT01836549) | Pediatric Brain Tumor Consortium | 2013-03-01 |
| Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 (NCT02430363) | Medical Research Council | 2013-03-01 |
| MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS (NCT01811121) | Hospices Civils de Lyon | 2013-02-01 |
| Bevacizumab Beyond Progression (BBP) (NCT01740258) | Duke University | 2013-01-01 |
| Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma (NCT01700569) | Institut Cancerologie de l'Ouest | 2013-01-01 |
| A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma (NCT01723020) | Kartos Therapeutics, Inc. | 2012-12-27 |
| Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas (NCT01721577) | Rush University Medical Center | 2012-12-01 |
| Proteome-based Personalized Immunotherapy of Glioblastoma (NCT01759810) | NeuroVita Clinic | 2012-12-01 |
| Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas (NCT01434602) | National Cancer Institute (NCI) | 2012-10-02 |
| Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma (NCT01250470) | Roswell Park Cancer Institute | 2012-09-05 |
| A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas (NCT01765088) | Sun Yat-sen University | 2012-09-01 |
| Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients (NCT01836536) | Center Eugene Marquis | 2012-09-01 |
| Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma (NCT01813877) | Jonsson Comprehensive Cancer Center | 2012-08-22 |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma (NCT01656980) | Shandong Lanjin Pharmaceuticals Co.,Ltd | 2012-08-01 |
| Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas (NCT01653834) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-07-01 |
| Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme (NCT01604590) | Medical University of South Carolina | 2012-07-01 |
| A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma (NCT01632228) | Hoffmann-La Roche | 2012-06-29 |
| Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors (NCT01609790) | National Cancer Institute (NCI) | 2012-06-04 |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma (NCT01637753) | Shandong Lanjin Pharmaceuticals Co.,Ltd | 2012-06-01 |
| CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII (NCT01454596) | National Cancer Institute (NCI) | 2012-05-16 |
| A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma (NCT01564914) | Tracon Pharmaceuticals Inc. | 2012-05-01 |
| PVSRIPO for Recurrent Glioblastoma (GBM) (NCT01491893) | Istari Oncology, Inc. | 2012-04-25 |
| Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors (NCT01535911) | Michigan State University | 2012-04-01 |
| Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients (NCT01579253) | Ludwig-Maximilians - University of Munich | 2012-04-01 |
| An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) (NCT01598597) | Genentech, Inc. | 2012-03-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Quality of Life and Patient Needs in Advanced High Grade Gliomas (NCT05039346) | Henry Ford Health System | 2012-02-11 |
| Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. (NCT01520870) | Grupo Español de Investigación en Neurooncología | 2012-02-01 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma (NCT01465347) | Diffusion Pharmaceuticals Inc | 2012-02-01 |
| Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas (NCT01514201) | National Cancer Institute (NCI) | 2012-02-01 |
| Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma (NCT01499251) | Actelion | 2012-01-01 |
| A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT01473901) | Novartis Pharmaceuticals | 2011-12-30 |
| A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. (NCT01441388) | Pfizer | 2011-12-01 |
| PET/CT Imaging of Malignant Brain Tumors With 124I-NM404 (NCT01516905) | University of Wisconsin, Madison | 2011-12-01 |
| Image Guided Reirradiation of High-grade Glioma (NCT02025231) | Rigshospitalet, Denmark | 2011-12-01 |
| A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (NCT01498328) | Celldex Therapeutics | 2011-12-01 |
| Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (NCT01480479) | Celldex Therapeutics | 2011-11-01 |
| Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma (NCT01478178) | Kintara Therapeutics, Inc. | 2011-10-01 |
| Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (NCT01443676) | University of Zurich | 2011-10-01 |
| Biomarkers for Prognosis of Glioblastoma (GBM) (NCT01493219) | University of Nebraska | 2011-09-20 |
| Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy (NCT01430351) | M.D. Anderson Cancer Center | 2011-09-14 |
| Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma (NCT01421524) | Celgene | 2011-09-12 |
| Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma (NCT01339052) | L. Nicolas Gonzalez Castro, MD, PhD | 2011-09-01 |
| Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma (NCT01403285) | Immatics Biotechnologies GmbH | 2011-08-01 |
| Bevacizumab With or Without Surgery for Adult Glioblastomas (NCT01413438) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-07-15 |
| New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma (NCT01174537) | Hadassah Medical Organization | 2011-07-01 |
| Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01310855) | University College, London | 2011-05-01 |
| Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma (NCT01310868) | University College, London | 2011-05-01 |
| Evaluating Tumor Pseudoprogression With FLT-PET and MRI (NCT01105988) | Massachusetts General Hospital | 2011-05-01 |
| A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors (NCT01351519) | MultiCare Health System Research Institute | 2011-05-01 |
| A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression (NCT01259869) | NCIC Clinical Trials Group | 2011-04-01 |
| Bosutinib in Adult Patients With Recurrent Glioblastoma (NCT01331291) | Massachusetts General Hospital | 2011-04-01 |
| HYPAZ: Hypertension Induced by Pazopanib (NCT01392352) | Cambridge University Hospitals NHS Foundation Trust | 2011-04-01 |
| Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma (NCT01507506) | Institut Claudius Regaud | 2011-03-15 |
| Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab (NCT01331616) | West Penn Allegheny Health System | 2011-03-01 |
| A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma (NCT01225510) | Pfizer | 2011-01-01 |
| Dendritic Cell Vaccine for Patients With Brain Tumors (NCT01204684) | Jonsson Comprehensive Cancer Center | 2010-10-08 |
| Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 (NCT01383135) | Stanford University | 2010-10-01 |
| Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (NCT01149109) | University Hospital, Bonn | 2010-10-01 |
| A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma (NCT01227434) | University of California, San Francisco | 2010-09-01 |
| Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor (NCT01171469) | Masonic Cancer Center, University of Minnesota | 2010-09-01 |
| Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma (NCT03388372) | Biotech Pharmaceutical Co., Ltd. | 2010-08-18 |
| A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma (NCT01156584) | Tocagen Inc. | 2010-07-01 |
| Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme (NCT04801147) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2010-06-26 |
| Dendritic Cell Vaccination for Patients with Solid Tumors (NCT01291420) | University Hospital, Antwerp | 2010-05-03 |
| Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 (NCT01082926) | City of Hope Medical Center | 2010-05-01 |
| Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma (NCT01149850) | Jonsson Comprehensive Cancer Center | 2010-04-28 |
| PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma (NCT01112527) | Massachusetts General Hospital | 2010-04-01 |
| Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors (NCT01111097) | University of Florida | 2010-04-01 |
| Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform (NCT01120639) | Stanford University | 2010-04-01 |
| Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme (NCT04002804) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2010-04-01 |
| A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes. (NCT01083719) | Medanta Institute of Clinical Research | 2010-04-01 |
| Radiosurgery Plus Bevacizumab in Glioblastoma (NCT01086345) | Case Comprehensive Cancer Center | 2010-02-01 |